International Journal of Molecular Sciences Article Interferon Beta Activity Is Modulated via Binding of Specific S100 Proteins Alexey S. Kazakov 1, Alexander D. Sofin 1, Nadezhda V. Avkhacheva 1, Alexander I. Denesyuk 1,2 , Evgenia I. Deryusheva 1, Victoria A. Rastrygina 1 , Andrey S. Sokolov 1, Maria E. Permyakova 1, Ekaterina A. Litus 1, Vladimir N. Uversky 1,3,* , Eugene A. Permyakov 1 and Sergei E. Permyakov 1,* 1 Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, Institutskaya str., 7, 142290 Pushchino, Russia; fenixfl
[email protected] (A.S.K.); AlSofi
[email protected] (A.D.S.);
[email protected] (N.V.A.); adenesyu@abo.fi (A.I.D.);
[email protected] (E.I.D.); certusfi
[email protected] (V.A.R.);
[email protected] (A.S.S.);
[email protected] (M.E.P.);
[email protected] (E.A.L.);
[email protected] (E.A.P.) 2 Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland 3 Department of Molecular Medicine and USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA * Correspondence:
[email protected] (V.N.U.);
[email protected] (S.E.P.); Tel.: +7-(495)-143-7741 (S.E.P.); Fax: +7-(4967)-33-05-22 (S.E.P.) Received: 25 November 2020; Accepted: 11 December 2020; Published: 13 December 2020 Abstract: Interferon-β (IFN-β) is a pleiotropic cytokine used for therapy of multiple sclerosis, which is also effective in suppression of viral and bacterial infections and cancer.